| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $934,661 ) |
| | 2024 | 2024 | SILOAM VISION, INC. | 1651 VILLAGE PARK LN | LAKE OSWEGO | OR | 97034-3774 | CLACKAMAS | USA | R44EY036778 | Ultrawide field non-mydriatic portable pediatric retinal imaging | 000 | 1 | NIH | 9/17/2024 | $881,796 |
| | 2024 | 2024 | SILOAM VISION, INC. | 1651 VILLAGE PARK LN | LAKE OSWEGO | OR | 97034-3774 | CLACKAMAS | USA | R44EY035596 | Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP) | 001 | 2 | NIH | 8/30/2024 | $52,865 |
| | 2024 | 2023 | SILOAM VISION, INC. | 1651 VILLAGE PARK LN | LAKE OSWEGO | OR | 97034-3774 | CLACKAMAS | USA | R44EY035596 | Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP) | 000 | 1 | NIH | 10/16/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,907,135 ) |
| | 2023 | 2023 | SILOAM VISION, INC. | 1651 VILLAGE PARK LN | LAKE OSWEGO | OR | 97034-3774 | CLACKAMAS | USA | R44EY035596 | Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP) | 000 | 1 | NIH | 9/19/2023 | $1,907,135 |
|
|
